Ivan Corazza

Prof. Ivan Corazza

Department of Experimental, Diagnostic and Specialty Medicine - DIMES - University of Bologna
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MRMatilde Roda
Matilde Roda
ICIvan Corazza
Ivan Corazza
MRMaria Letizia Bacchi Reggiani
Maria Letizia Bacchi Reggiani
MPMarco Pellegrini
Marco Pellegrini
LTLeonardo Taroni
Leonardo Taroni
PVPiera Versura
Piera Versura
Background—It is recognized that inflammation is an underlying cause of dry eye disease (DED), with cytokine release involved. We systematically reviewed literature with meta-analyses to quantitatively summarize the levels of tear cytokines in DED. Methods—The PubMed, Embase, Web of Science, Ovid, Cochrane, and Scopus databases were reviewed until September 2019, and original articles investigating tear cytokines in DED patients were included. Differences of cytokines levels of DED patients and controls were summarized by standardized mean differences (SMD) using a random effects model. Study quality was assessed by applying Newcastle-Ottawa-Scale and the GRADE quality score. Methods of analytical procedures were included as covariate. Results—Thirteen articles investigating 342 DED patients and 205 healthy controls were included in the meta-analysis. The overall methodological quality of these studies was moderate. Systematic review of the selected articles revealed that DED patients had higher tear levels of interleukin (IL)-1β, IL-6, chemokine IL-8, IL-10, interferon-γ, IFN-γ, and tumor necrosis factor-α, TNF-α as compared to controls. Evidence was less strong for IL-2 and IL-17A. Conclusions—Data show that levels of tear cytokines in DED and control display a great variability, and further studies of higher quality enrolling a higher number of subjects are needed, to define a cut-off value.

1 March 2012 in Sleep Medicine
Verified
Journal Article
Closed access
GCGiovanna Calandra-Buonaura
Giovanna Calandra-Buonaura
Nicola ToschiNicola Toschi
Nicola Toschi
FPFederica Provini
Federica Provini
ICIvan Corazza
Ivan Corazza
Francesca BisulliFrancesca Bisulli
Francesca Bisulli
Pietro CortelliPietro Cortelli
Pietro Cortelli

31 August 2020 in Aging Clinical and Experimental Research
Verified
Journal Article
Open access
PDF file
SFSirio Fiorino
Sirio Fiorino
CGClaudio Gallo
Claudio Gallo
MZMaddalena Zippi
Maddalena Zippi
SSSergio Sabbatani
Sergio Sabbatani
RMRoberto Manfredi
Roberto Manfredi
Dario de BiaseDario de Biase
Dario de Biase
Background: In December 2019, a novel human-infecting coronavirus, SARS-CoV-2, had emerged. The WHO has classified the epidemic as a “public health emergency of international concern”. A dramatic situation has unfolded with thousands of deaths, occurring mainly in the aged and very ill people. Epidemiological studies suggest that immune system function is impaired in elderly individuals and these subjects often present a deficiency in fat-soluble and hydrosoluble vitamins.Methods: We searched for reviews describing the characteristics of autoimmune diseases and the available therapeutic protocols for their treatment. We set them as a paradigm with the purpose to uncover common pathogenetic mechanisms between these pathological conditions and SARS-CoV-2 infection. Furthermore, we searched for studies describing the possible efficacy of vitamins A, D, E, and C in improving the immune system function.Results: SARS-CoV-2 infection induces strong immune system dysfunction characterized by the development of an intense proinflammatory response in the host, and the development of a life-threatening condition defined as cytokine release syndrome (CRS). This leads to acute respiratory syndrome (ARDS), mainly in aged people. High mortality and lethality rates have been observed in elderly subjects with CoV-2-related infection.Conclusions: Vitamins may shift the proinflammatory Th17-mediated immune response arising in autoimmune diseases towards a T-cell regulatory phenotype. This review discusses the possible activity of vitamins A, D, E, and C in restoring normal antiviral immune system function and the potential therapeutic role of these micronutrients as part of a therapeutic strategy against SARS-CoV-2 infection.

4 June 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
MATTEO MICUCCIMATTEO MICUCCI
MATTEO MICUCCI
Michele ProttiMichele Protti
Michele Protti
RARita Aldini
Rita Aldini
Maria FrosiniMaria Frosini
Maria Frosini
ICIvan Corazza
Ivan Corazza
Roberta BudriesiRoberta Budriesi
Roberta Budriesi
A new Thymus vulgaris L. solid essential oil (SEO) formulation composed of liquid EO linked to solid excipients has been chemically analysed and evaluated for its intestinal spasmolytic and antispastic effects in ex vivo ileum and colon of guinea pig and compared with liquid EO and excipients. Liquid EO and solid linked EO were analysed by original capillary electrochromatography coupled to diode array detection (CEC-DAD) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodologies. The main bioactive constituents are thymol and carvacrol, with minor constituents for a total of 12 selected analysed compounds. Liquid EO was the most effective in decreasing basal contractility in ileum and colon; excipients addiction permitted normal contractility pattern in solid linked EO SEO. In ileum and colon, the Thymus vulgaris L. solid formulation exerted the relaxant activity on K+-depolarized intestinal smooth muscle as well as liquid EO. The solid essential oil exhibits antimicrobial activity against different strains (Staphylococcus aureus, Streptococcus pyogenes, Pseudomonas aeruginosa, Escherichia coli, Salmonella Thyphimurium, Candida albicans) similarly to liquid oil, with activity against pathogen, but not commensal strains (Bifidobacterium Breve, Lactobacillus Fermentum) in intestinal homeostasis. Therefore, Thymus vulgaris L. solid essential oil formulation can be proposed as a possible spasmolytic and antispastic tool in medicine.

1 June 2009 in Physica Medica
Verified
Journal Article
Closed access
RZRomano Zannoli
Romano Zannoli
ICIvan Corazza
Ivan Corazza
ABAngelo Branzi
Angelo Branzi

1 June 2005 in International Journal of Cardiology
Verified
Journal Article
Closed access
Giuseppe BorianiGiuseppe Boriani
Giuseppe Boriani
IDIgor Diemberger
Igor Diemberger
MBMauro Biffi
Mauro Biffi
CCClaudia Camanini
Claudia Camanini
CVCinzia Valzania
Cinzia Valzania
ABAngelo Branzi
Angelo Branzi